New scan could spot hidden cancers in the belly
NCT ID NCT07219238
First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time
Summary
This study tests a new PET/CT scan using a radioactive tracer called GEH300079 to detect peritoneal carcinomatosis—cancer that has spread to the lining of the abdomen—in people with colorectal, stomach, ovarian, or pancreatic cancer. About 175 adults with known or suspected spread will receive the scan before planned surgery. The goal is to see if this scan is more accurate than standard imaging at finding cancer in different abdominal regions.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
GEH300079 (68Ga) injection (a radioactive tracer used in PET/CT imaging)
What this could lead to
If successful, this could provide a more accurate, non-invasive way to detect cancer spread in the abdomen, helping doctors plan better surgeries.
What could go wrong
This is an early-to-mid-stage trial with only 175 participants, so results may not apply to all patients. The scan may not be more accurate than current methods.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for COLORECTAL CANCER are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
BAMF Health
NOT_YET_RECRUITINGGrand Rapids, Michigan, 49503, United States
-
Karolinska Universitetssjukhuset
RECRUITINGStockholm, 17176, Sweden